{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:08:26Z","timestamp":1790482106531,"version":"4.1.0"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":1616,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Radioiodine (131I) is the treatment of choice for hyperthyroidism in cats, but current 131I-dosing protocols can induce iatrogenic hypothyroidism and expose azotemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To develop a cat-specific algorithm to calculate the lowest 131I dose to resolve hyperthyroidism, while minimizing risk of iatrogenic hypothyroidism and subsequent azotemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>One thousand and four hundred hyperthyroid cats treated with 131I.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective case series (before-and-after study). All cats had serum concentrations of thyroxine (T4), triiodothyronine (T3), and thyroid-stimulating hormone (TSH) measured (off methimazole \u22651\u00a0week). Using thyroid scintigraphy, each cat's thyroid volume and percent uptake of 99mTc-pertechnatate (TcTU) were determined. An initial 131I dose was calculated by averaging dose scores for T4\/T3 concentrations, thyroid volume, and TcTU; 80% of that composite dose was administered. Twenty-four hours later, percent 131I uptake was measured, and additional 131I administered, as needed, to deliver an adequate radiation dose to the thyroid tumor(s). Serum concentrations of T4, TSH, and creatinine were determined 6 to 12\u2009months later.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median calculated 131I dose was 1.9\u00a0mCi (range, 1.0-10.6\u00a0mCi); 1380 cats required additional 131I administration on day 2. Of the cats, 1047 (74.8%) became euthyroid, 57 (4.1%) became overtly hypothyroid, 240 (17.1%) became subclinically hypothyroid, and 56 (4%) remained hyperthyroid. More overtly (71.9%) and subclinically (39.6%) hypothyroid cats developed azotemia than euthyroid cats (14.2%; P\u2009&amp;lt;\u2009.0001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Our algorithm for calculating individual 131I doses resulted in cure rates similar to historical treatment rates, despite much lower 131I doses. This algorithm appears to lower prevalence of both 131I-induced overt hypothyroidism and azotemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.16228","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T06:49:41Z","timestamp":1628146181000},"page":"2140-2151","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A dosing algorithm for individualized radioiodine treatment of cats with hyperthyroidism"],"prefix":"10.1093","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3016-1855","authenticated-orcid":false,"given":"Mark E.","family":"Peterson","sequence":"first","affiliation":[{"name":"Animal Endocrine Clinic , New York, New York,","place":["USA"]},{"name":"College of Veterinary Medicine, Cornell University , Ithaca, New York,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0477-1780","authenticated-orcid":false,"given":"Mark","family":"Rishniw","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Cornell University , Ithaca, New York,","place":["USA"]},{"name":"Veterinary Information Network , Davis, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"2026020303473297600_jvim16228-bib-0001","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2460\/javma.2005.226.1671","article-title":"Association of the risk of development of hypothyroidism after iodine 131 treatment with the pretreatment pattern of sodium pertechnetate Tc 99m uptake in the thyroid gland in cats with hyperthyroidism: 165 cases (1990-2002)","volume":"226","author":"Nykamp","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303473297600_jvim16228-bib-0002","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/jvim.14646","article-title":"Efficacy of low-dose (2 millicurie) versus standard-dose (4 millicurie) radioiodine treatment for cats with mild-to-moderate hyperthyroidism","volume":"31","author":"Lucy","year":"2017","journal-title":"J Vet Intern Med"},{"key":"2026020303473297600_jvim16228-bib-0003","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1111\/jvim.15296","article-title":"Investigation of a novel variable dosing protocol for radioiodine treatment of feline hyperthyroidism","volume":"32","author":"Morre","year":"2018","journal-title":"J Vet Intern Med"},{"key":"2026020303473297600_jvim16228-bib-0004","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/jsap.13057","article-title":"Thyroid and renal function in cats following low-dose radioiodine (111Mbq) therapy (3 mCI)","volume":"60","author":"Finch","year":"2019","journal-title":"J Small Anim Pract"},{"key":"2026020303473297600_jvim16228-bib-0005","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/1098612X19884155","article-title":"Assessment of treatment outcomes in hyperthyroid cats treated with an orally administered fixed dose of radioiodine","volume":"22","author":"Yu","year":"2020","journal-title":"J Feline Med Surg"},{"key":"2026020303473297600_jvim16228-bib-0006","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/vr.161.21.711","article-title":"Changes in the glomerular filtration rate of 27 cats with hyperthyroidism after treatment with radioactive iodine","volume":"161","author":"Boag","year":"2007","journal-title":"Vet Rec"},{"key":"2026020303473297600_jvim16228-bib-0007","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/1098612X17713854","article-title":"Predictive value of scintigraphic (semi-) quantitative thyroid parameters on radioiodine therapy outcome in hyperthyroid cats","volume":"20","author":"Volckaert","year":"2018","journal-title":"J Feline Med Surg"},{"key":"2026020303473297600_jvim16228-bib-0008","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/1098612X18822396","article-title":"Prevalence of iatrogenic hypothyroidism in hyperthyroid cats treated with radioiodine using an individualised scoring system","volume":"21","author":"Fernandez","year":"2019","journal-title":"J Feline Med Surg"},{"key":"2026020303473297600_jvim16228-bib-0009","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1740-8261.2002.tb01054.x","article-title":"Predictors of response to radioiodine therapy in hyperthyroid cats","volume":"43","author":"Chun","year":"2002","journal-title":"Vet Radiol Ultrasound"},{"key":"2026020303473297600_jvim16228-bib-0010","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/jsap.12695","article-title":"Serum thyroxine and thyroid-stimulating hormone concentration in hyperthyroid cats that develop azotaemia after radioiodine therapy","volume":"58","author":"Peterson","year":"2017","journal-title":"J Small Anim Pract"},{"key":"2026020303473297600_jvim16228-bib-0011","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/jvim.15036","article-title":"Evaluation of serum symmetric dimethylarginine concentration as a marker for masked chronic kidney disease in cats with hyperthyroidism","volume":"32","author":"Peterson","year":"2018","journal-title":"J Vet Intern Med"},{"key":"2026020303473297600_jvim16228-bib-0012","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1939-1676.2010.0566.x","article-title":"Association of iatrogenic hypothyroidism with azotemia and reduced survival time in cats treated for hyperthyroidism","volume":"24","author":"Williams","year":"2010","journal-title":"J Vet Intern Med"},{"key":"2026020303473297600_jvim16228-bib-0013","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1939-1676.2010.0550.x","article-title":"Survival and the development of azotemia after treatment of hyperthyroid cats","volume":"24","author":"Williams","year":"2010","journal-title":"J Vet Intern Med"},{"key":"2026020303473297600_jvim16228-bib-0014","first-page":"156","article-title":"Feline Endocrinology","author":"Williams","year":"2019"},{"key":"2026020303473297600_jvim16228-bib-0015","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/thy.2010.0403","article-title":"Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131-I: practice recommendations of the American Thyroid Association","volume":"21","author":"Sisson","year":"2011","journal-title":"Thyroid"},{"key":"2026020303473297600_jvim16228-bib-0016","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/jaba.691","article-title":"The consecutive controlled case series: design, data-analytics, and reporting methods supporting the study of generality","volume":"53","author":"Hagopian","year":"2020","journal-title":"J Appl Behav Anal"},{"key":"2026020303473297600_jvim16228-bib-0017","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/jvim.13585","article-title":"Evaluation of serum thyroid-stimulating hormone concentration as a diagnostic test for hyperthyroidism in cats","volume":"29","author":"Peterson","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020303473297600_jvim16228-bib-0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.domaniend.2019.106389","article-title":"Short-term biological variation of serum thyroid hormones concentrations in clinically healthy cats","volume":"71","author":"Prieto","year":"2020","journal-title":"Domest Anim Endocrinol"},{"key":"2026020303473297600_jvim16228-bib-0019","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/vru.12165","article-title":"Thyroid scintigraphy findings in 2096 cats with hyperthyroidism","volume":"56","author":"Peterson","year":"2015","journal-title":"Vet Radiol Ultrasound"},{"key":"2026020303473297600_jvim16228-bib-0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/vru.12360","article-title":"Evaluation of quantitative thyroid scintigraphy for diagnosis and staging of disease severity in cats with hyperthyroidism: comparison of the percent thyroidal uptake of pertechnetate to the thyroid-to-salivary ratio and thyroid-to-background ratios","volume":"57","author":"Peterson","year":"2016","journal-title":"Vet Radiol Ultrasound"},{"key":"2026020303473297600_jvim16228-bib-0021","first-page":"20","article-title":"Suspected thyroid carcinoma in cats: treatment with radioiodine","volume":"3","author":"Xifra","year":"2018","journal-title":"Clinoncovet Rev Cl\u00edn Oncol Vet"},{"key":"2026020303473297600_jvim16228-bib-0022","first-page":"169","article-title":"Feline Endocrinology","author":"Broome","year":"2019"},{"key":"2026020303473297600_jvim16228-bib-0023","first-page":"1040","article-title":"Radioiodine treatment of feline hyperthyroidism: measuring 24-hour thyroid 131 I uptake helps predict treatment failure or development of iatrogenic hypothyroidism","volume":"33","author":"Peterson","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026020303473297600_jvim16228-bib-0024","first-page":"227","article-title":"Feline Endocrinology","author":"Peterson","year":"2019"},{"key":"2026020303473297600_jvim16228-bib-0025","first-page":"260","article-title":"August's Consultations in Feline Internal Medicine","author":"Peterson","year":"2016"},{"key":"2026020303473297600_jvim16228-bib-0026","first-page":"281","article-title":"Feline Endocrinology","author":"Peterson","year":"2019"},{"key":"2026020303473297600_jvim16228-bib-0027","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2460\/javma.1995.207.11.1422","article-title":"Radioiodine treatment of 524 cats with hyperthyroidism","volume":"207","author":"Peterson","year":"1995","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303473297600_jvim16228-bib-0028","first-page":"367","article-title":"Goodness-of-Fit Techniques","author":"D'Agostino","year":"1986"},{"key":"2026020303473297600_jvim16228-bib-0029","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/0002-8703(88)90791-0","article-title":"The box-plot: an exploratory analysis graph for biomedical publications","volume":"116","author":"Simpson","year":"1988","journal-title":"Am Heart J"},{"key":"2026020303473297600_jvim16228-bib-0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-5573-8-1","article-title":"WINPEPI updated: computer programs for epidemiologists, and their teaching potential","volume":"8","author":"Abramson","year":"2011","journal-title":"Epidemiol Perspect Innov"},{"key":"2026020303473297600_jvim16228-bib-0031","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1748-5827.1994.tb03287.x","article-title":"Radioactive iodine therapy for feline hyperthyroidism: efficacy and administration routes","volume":"35","author":"Mooney","year":"1994","journal-title":"J Small Anim Pract"},{"key":"2026020303473297600_jvim16228-bib-0032","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/1098612X15572416","article-title":"Prevalence and degree of thyroid pathology in hyperthyroid cats increases with disease duration: a cross-sectional analysis of 2096 cats referred for radioiodine therapy","volume":"18","author":"Peterson","year":"2016","journal-title":"J Feline Med Surg"},{"key":"2026020303473297600_jvim16228-bib-0033","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5603\/NMR.2012.0003","article-title":"Iodine isotope 131-I therapy for toxic nodular goitre: treatment efficacy parameters","volume":"15","author":"Szumowski","year":"2012","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"2026020303473297600_jvim16228-bib-0034","first-page":"28","article-title":"Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake","volume":"8","author":"Ruchala","year":"2005","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"2026020303473297600_jvim16228-bib-0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2265.2005.02218.x","article-title":"Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20\u2009years' retrospective study","volume":"62","author":"Ceccarelli","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026020303473297600_jvim16228-bib-0036","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMct1007101","article-title":"Radioiodine therapy for hyperthyroidism","volume":"364","author":"Ross","year":"2011","journal-title":"N Engl J Med"},{"key":"2026020303473297600_jvim16228-bib-0037","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2967\/jnumed.112.105148","article-title":"The SNM practice guideline for therapy of thyroid disease with 131I","volume":"53","author":"Silberstein","year":"2012","journal-title":"J Nucl Med"},{"key":"2026020303473297600_jvim16228-bib-0038","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0001-2998(78)80010-5","article-title":"The treatment of hyperthyroidism with iodine-131","volume":"8","author":"Beierwaltes","year":"1978","journal-title":"Semin Nucl Med"},{"key":"2026020303473297600_jvim16228-bib-0039","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/BF00173483","article-title":"Long-term results of two schedules of radioiodine treatment for toxic multinodular goitre","volume":"20","author":"Huysmans","year":"1993","journal-title":"Eur J Nucl Med"},{"key":"2026020303473297600_jvim16228-bib-0040","article-title":"UpToDate","author":"Ross","year":"2019","edition":"12th ed."},{"key":"2026020303473297600_jvim16228-bib-0041","first-page":"48","article-title":"The relationship between serum triiodothyronine and thyroxine concentrations in hyperthyroidism","volume":"42","author":"de Rave","year":"1993","journal-title":"Neth J Med"},{"key":"2026020303473297600_jvim16228-bib-0042","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ando.2011.04.008","article-title":"Increased thyroidal T4 to T3 conversion in autonomously functioning thyroid adenoma: from euthyroidism to thyrotoxicosis","volume":"72","author":"Solter","year":"2011","journal-title":"Ann Endocrinol (Paris)"},{"key":"2026020303473297600_jvim16228-bib-0043","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1530\/EJE-13-0533","article-title":"Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study","volume":"169","author":"Carle","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2026020303473297600_jvim16228-bib-0044","doi-asserted-by":"crossref","first-page":"T97","DOI":"10.1530\/JOE-14-0461","article-title":"Animal models of disease: feline hyperthyroidism: an animal model for toxic nodular goiter","volume":"223","author":"Peterson","year":"2014","journal-title":"J Endocrinol"},{"key":"2026020303473297600_jvim16228-bib-0045","first-page":"131","article-title":"Results of TcTUs-optimized radioiodine therapy in multifocal and disseminated autonomy","volume":"38","author":"Dunkelmann","year":"1999","journal-title":"Nuklearmedizin"},{"key":"2026020303473297600_jvim16228-bib-0046","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s002590000285","article-title":"Radioiodine therapy for Plummer's disease based on the thyroid uptake of technetium-99m pertechnetate","volume":"27","author":"Meller","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"2026020303473297600_jvim16228-bib-0047","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s00259-005-0051-9","article-title":"Dose selection for radioiodine therapy of borderline hyperthyroid patients according to thyroid uptake of 99mTc-pertechnetate: applicability to unifocal thyroid autonomy?","volume":"33","author":"Reinhardt","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"2026020303473297600_jvim16228-bib-0048","first-page":"S63","article-title":"Radioiodine treatment of Plummer's disease","volume":"106","author":"Moser","year":"1998","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2026020303473297600_jvim16228-bib-0049","first-page":"1632","article-title":"Optimized dose planning of radioiodine therapy of benign thyroidal diseases","volume":"34","author":"Bockisch","year":"1993","journal-title":"J Nucl Med"},{"key":"2026020303473297600_jvim16228-bib-0050","first-page":"1266","article-title":"Procedure guideline for thyroid uptake measurement: 1.0. Society of Nuclear Medicine","volume":"37","author":"Becker","year":"1996","journal-title":"J Nucl Med"},{"key":"2026020303473297600_jvim16228-bib-0051","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s00259-013-2387-x","article-title":"EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases","volume":"40","author":"Hanscheid","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026020303473297600_jvim16228-bib-0052","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2460\/javma.1984.184.05.554","article-title":"Radioactive iodine therapy in cats with hyperthyroidism","volume":"184","author":"Turrel","year":"1984","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303473297600_jvim16228-bib-0053","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2460\/javma.1986.188.09.1038","article-title":"Serum thyroxine concentrations after radioactive iodine therapy in cats with hyperthyroidism","volume":"188","author":"Meric","year":"1986","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303473297600_jvim16228-bib-0054","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2460\/ajvr.1988.49.02.193","article-title":"Predictive value of tracer studies for 131-I treatment in hyperthyroid cats","volume":"49","author":"Broome","year":"1988","journal-title":"Am J Vet Res"},{"key":"2026020303473297600_jvim16228-bib-0055","first-page":"91","article-title":"The importance of the radioiodine test for the calculation of the therapeutic dose in benign thyroid diseases","volume":"32","author":"Nuchel","year":"1993","journal-title":"Nuklearmedizin"},{"key":"2026020303473297600_jvim16228-bib-0056","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12020-017-1267-8","article-title":"Comparing pre-therapeutic 124-I and 131-I uptake tests with intra-therapeutic 131-I uptake in benign thyroid disorders","volume":"56","author":"Guhne","year":"2017","journal-title":"Endocrine"},{"key":"2026020303473297600_jvim16228-bib-0057","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-2004-822681","article-title":"Peri- and pretherapeutic dosimetry in radioiodine therapy of benign thyroid diseases","volume":"27","author":"Eschner","year":"2004","journal-title":"Nuklearmediziner"},{"key":"2026020303473297600_jvim16228-bib-0058","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-0038-1632207","article-title":"Two-step radioiodine therapy in benign thyroid diseases during a single hospital visit\u2014observations on 100 patients","volume":"38","author":"Khandani","year":"1999","journal-title":"Nuklearmedizin"},{"key":"2026020303473297600_jvim16228-bib-0059","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1148\/radiographics.19.2.g99mr30481","article-title":"Radiation detectors in nuclear medicine","volume":"19","author":"Ranger","year":"1999","journal-title":"Radiographics"},{"key":"2026020303473297600_jvim16228-bib-0060","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cvsm.2007.03.005","article-title":"Nuclear imaging and radiation therapy in canine and feline thyroid disease","volume":"37","author":"Feeney","year":"2007","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020303473297600_jvim16228-bib-0061","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.2460\/ajvr.2003.64.1242","article-title":"Relationship between orally administered dose, surface emission rate for gamma radiation, and urine radioactivity in radioiodine-treated hyperthyroid cats","volume":"64","author":"Feeney","year":"2003","journal-title":"Am J Vet Res"},{"key":"2026020303473297600_jvim16228-bib-0062","article-title":"Part 20\u2014Standard for Protection against Radiation; Subpart C\u2014Occupational Dose Limits","author":"United States Nuclear Regulatory Commission","year":"2021"},{"key":"2026020303473297600_jvim16228-bib-0063","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/1098612X15575385","article-title":"Effects of feline hyperthyroidism on kidney function: a review","volume":"18","author":"Vaske","year":"2016","journal-title":"J Feline Med Surg"},{"key":"2026020303473297600_jvim16228-bib-0064","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/jvim.14591","article-title":"Evaluation of body weight, body condition, and muscle condition in cats with hyperthyroidism","volume":"30","author":"Peterson","year":"2016","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvim.16228","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvim.16228","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/35\/5\/2140\/66672978\/jvim16228.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/35\/5\/2140\/66672978\/jvim16228.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:47:58Z","timestamp":1770108478000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/35\/5\/2140\/8448567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.16228","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9]]},"published":{"date-parts":[[2021,9,1]]},"assertion":[{"value":"2021-04-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}